Alnylam Pharmaceuticals Inc Note 0 09/15

Alnylam Pharmaceuticals Inc Note 0 09/15 is a security (CUSIP 02043QAC1) tracked across SEC portfolio filings. 1 institutional managers reported $14.1M on Form 13F as of 2026-03-31; 10 registered fund positions totaling $29.5M via N-PORT as of 2026-05-31.

Summary

Top institutional holders (Form 13F)

ManagerLocationValueShares
SILVERBACK ASSET MANAGEMENT LLCCHAPEL HILL, NC$14.1M15,161,000

Top fund holders (N-PORT)

FundRegistrantValue% of fund
Calamos Market Neutral Income FundCALAMOS INVESTMENT TRUST/IL$11.5M6.51%
Miller Convertible Bond FundMiller Investment Trust$7.7M204.01%
Putnam Convertible Securities FundPutnam Convertible Securities Fund$4.8M86.18%
Global Opportunities PortfolioGlobal Opportunities Portfolio$3.2M2.35%
Calvert Bond FundCalvert Social Investment Fund$1.2M2.85%
BNY Mellon Core Plus FundBNY Mellon Absolute Insight Funds, Inc.$558K2.19%
Putnam Diversified Income TrustPutnam Diversified Income Trust$376K4.09%
Putnam Premier Income TrustPutnam Premier Income Trust$101K2.85%
Putnam Master Intermediate Income TrustPutnam Master Intermediate Income Trust$46K2.84%
Putnam High Yield FundPutnam High Yield Fund$39K0.47%

More